KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Cash from Discontinued Operations (2022 - 2026)

TherapeuticsMD filings provide 6 years of Cash from Discontinued Operations readings, the most recent being 8000.0 for Q1 2026.

  • On a quarterly basis, Cash from Discontinued Operations rose 38.46% to 8000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 25000.0, a 96.38% increase, with the full-year FY2025 number at 30000.0, up 93.15% from a year prior.
  • Cash from Discontinued Operations hit 8000.0 in Q1 2026 for TherapeuticsMD, down from 7000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 136529000.0 in Q2 2022 to a low of 23368000.0 in Q1 2023.
  • Median Cash from Discontinued Operations over the past 5 years was 13000.0 (2025), compared with a mean of 10874176.47.
  • The widest YoY moves for Cash from Discontinued Operations: up 141.23% in 2025, down 105.42% in 2025.
  • TherapeuticsMD's Cash from Discontinued Operations stood at 92770000.0 in 2022, then crashed by 103.11% to 2881000.0 in 2023, then surged by 99.83% to 5000.0 in 2024, then tumbled by 40.0% to 7000.0 in 2025, then dropped by 14.29% to 8000.0 in 2026.
  • The last three reported values for Cash from Discontinued Operations were 8000.0 (Q1 2026), 7000.0 (Q4 2025), and 47000.0 (Q3 2025) per Business Quant data.